Breathe Well Live Well
|
AstraZeneca enters into $232m asthma drug deal with Synairgen
Pharmaceutical Business Review AstraZeneca has entered into a global licence agreement with Synairgen for SNG001, a new, inhaled interferon beta (IFN-beta) being developed for the treatment of respiratory tract viral infections in patients with severe asthma. AstraZeneca … |
View full post on asthma – Google News
|
MediciNova Enters Into a $20 Million Common Stock Purchase Agreement With …
NASDAQ MediciNova will use the net proceeds from any sales of its stock to advance MediciNova's development activities for its lead programs, MN-221 (bedoradrine sulfate) in development for the treatment of acute asthma and chronic obstructive pulmonary … |
View full post on asthma – Google News
|
Asthma education enters schools
Columbus Other Paper Ten schools in Franklin County have enrolled in a new program sponsored by The Breathing Association to educate the community on air quality and asthma in schools. Central Ohio has one of the highest rates of childhood asthma in the nation. … |
View full post on asthma – Google News
|
Nanotech Industries International Inc. Enters Into Definitive Agreement With …
MarketWatch (press release) In smaller amounts, isocyanates can also sensitize workers, making them subject to severe asthma attacks if they are exposed again. Death from severe asthma … |
View full post on asthma – Google News